CCB Safety Study in Treatment of Hypertension of ADPKD
Launched by KYORIN UNIVERSITY · Oct 9, 2007
Trial Information
Current as of June 13, 2025
Unknown status
Keywords
ClinConnect Summary
No description provided
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • ADPKD patients.
- • Blood pressure measured at out-patient setting is above 130/85 mmHg.
- • Age between 20 and 60 years old.
- • Plasma creatinine less than 2.0mg in man and 1.5mg in woman.
- • Patients give informed consent.
- Exclusion Criteria:
- • Patients with severe cardiovascular and hepatic disorders.
- • Patients with complications of central nervous vascular disorders.
- • Women who are breast feeding and females of childbearing potential who are not using acceptable contraceptive methods.
- • Patients currently engaging in other experimental protocol.
- • Patients with intracranial aneurysma.
- • Patients who must use diuretics.
- • Allergic patients to Candesartan or Cilnidipine.
- • Patients whose hypertension is not controlled by medication of this protocol.
About Kyorin University
Kyorin University is a distinguished academic institution located in Japan, dedicated to advancing medical research and education. With a strong emphasis on innovation and collaboration, the university sponsors a variety of clinical trials aimed at improving healthcare outcomes and contributing to the global body of medical knowledge. Kyorin University is committed to upholding the highest ethical standards in research, fostering a multidisciplinary approach that integrates cutting-edge science with clinical practice, ultimately enhancing patient care and treatment options. Through its robust research programs and partnerships, Kyorin University continues to play a pivotal role in the development of novel therapeutic strategies and interventions.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Mitaka, Tokyo, Japan
Chiba, Chiba, , Japan
Kanagawa, , Japan
Tokyo, , Japan
Tokyo, , Japan
Tokyo, , Japan
Patients applied
Trial Officials
Eiji Higashihara, M.D.
Study Chair
Kyorin University, School of Medicine
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials